We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 1-20 of 453 results
  1. CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS

    Myelodysplastic syndromes (MDS) are myeloid neoplasms presenting with dysplasia in the bone marrow (BM) and peripheral cytopenia. In most patients...

    Karin Bauer, Sigrid Machherndl-Spandl, ... Peter Valent in Leukemia
    Article 06 September 2023
  2. Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors

    Cancer immunotherapies strive to overcome tumor-induced immune suppression and activate antitumor immune responses. Although cytotoxic T lymphocytes...

    M Costa-Garcia, JJ Rojas, ... R Moreno in Cancer Immunology, Immunotherapy
    Article Open access 05 January 2024
  3. Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial

    Aims/hypothesis

    Infection with coxsackie B viruses (CVBs) can cause diseases ranging from mild common cold-type symptoms to severe life-threatening...

    Heikki Hyöty, Susanna Kääriäinen, ... Miguel Sanjuan in Diabetologia
    Article Open access 19 February 2024
  4. Interferon Alpha-Expressing Oncolytic Adenovirus for Treatment of Esophageal Adenocarcinoma

    Introduction

    Esophageal adenocarcinoma (EAC) has increased in incidence in Western countries, and its poor prognosis necessitates the development of...

    Christopher J. LaRocca, Amanda O. Salzwedel, ... Masato Yamamoto in Annals of Surgical Oncology
    Article 29 July 2021
  5. Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma

    Background

    T cell with chimeric antigen receptors (CAR-T) has presented remarkable efficacy for blood cancer as an emerging immunotherapy. However,...

    Jianhan Huang, Meijun Zheng, ... Liangxue Zhou in Cancer Immunology, Immunotherapy
    Article 04 February 2021
  6. Acute myocarditis during adjuvant therapies for breast cancer: a case report

    Background

    With the improvement of optimal perioperative drug therapy for breast cancer patients, physicians now have to treat the adverse effects and...

    Yumiko Ushiyama, Yoshiya Horimoto, ... Mitsue Saito in Surgical Case Reports
    Article Open access 23 March 2023
  7. Pericardial effusion caused by viral pericarditis in a patient receiving peritoneal dialysis

    Background

    Acute pericarditis causes acute inflammation of the pericardium. Although most cases of pericarditis are idiopathic with no identifiable...

    Masahiro Egawa, Shungo Fujii, ... Takafumi Ito in Renal Replacement Therapy
    Article Open access 18 April 2022
  8. An inactivated novel chimeric FAdV-4 containing fiber of FAdV-8b provides full protection against hepatitis-hydropericardium syndrome and inclusion body hepatitis

    Fowl adenovirus serotype 4 (FAdV-4) and FAdV-8b are causative agents of hepatitis-hydropericardium syndrome (HHS) and inclusion body hepatitis (IBH),...

    Baiyu Wang, Mingzhen Song, ... Jun Zhao in Veterinary Research
    Article Open access 30 September 2022
  9. Cardiac arrhythmias in viral infections

    Background

    The current COVID-19 pandemic has led to many studies examining its arrhythmogenic effects. However, there are many other viruses that are...

    Paul Y. Lee, Hasan Garan, ... Hirad Yarmohammadi in Journal of Interventional Cardiac Electrophysiology
    Article 16 March 2023
  10. The countdown to type 1 diabetes: when, how and why does the clock start?

    ‘The clock to type 1 diabetes has started when islet antibodies are first detected’, commented George Eisenbarth with regard to the pathogenesis of...

    Anette-Gabriele Ziegler in Diabetologia
    Article Open access 26 May 2023
  11. Oncolytic virotherapy: basic principles, recent advances and future directions

    Oncolytic viruses (OVs) have attracted growing awareness in the twenty-first century, as they are generally considered to have direct oncolysis and...

    Danni Lin, Yinan Shen, Tingbo Liang in Signal Transduction and Targeted Therapy
    Article Open access 11 April 2023
  12. Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia

    The use of oncolytic viruses has emerged as a promising therapeutic approach due to the features of these viruses, which selectively replicate and...

    Zixuan Wang, Wenmo Liu, ... Xianghui Yu in Signal Transduction and Targeted Therapy
    Article Open access 24 April 2020
  13. Changing clinical characteristics of pediatric inpatients with pneumonia during COVID-19 pandamic: a retrospective study

    Background

    The COVID-19 pandemic have impacts on the prevalence of other pathogens and people’s social lifestyle. This study aimed to compare the...

    Mengxue Chen, Yabing Zhou, ... Li Hua in Italian Journal of Pediatrics
    Article Open access 23 April 2024
  14. Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma

    Immune checkpoint inhibitors including anti-programmed cell death 1 (PD-1) antibody have recently improved clinical outcome in certain cancer...

    Yusuke Mochizuki, Hiroshi Tazawa, ... Toshiyoshi Fujiwara in Cancer Immunology, Immunotherapy
    Article 05 November 2020
  15. Wuhan 3 years after the outbreak of the pandemic—cardiological insights and perspectives

    In November 2019, Wuhan, a city in Central China, became the center of an outbreak of pneumonia of unknown cause, which was later named “coronavirus...

    Chen Chen, Wu He, Dao Wen Wang in Herz
    Article 27 April 2023
  16. Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical

    With the in-depth research and wide application of immunotherapy recently, new therapies based on oncolytic viruses are expected to create new...

    Chao Tang, Lan Li, ... Liping Zhong in Clinical and Translational Oncology
    Article 25 May 2022
  17. Oncolytic adenoviruses and the treatment of pancreatic cancer: a review of clinical trials

    Purpose

    Pancreatic ductal adenocarcinoma (PDAC) remains a common and difficult cancer to treat. Surgical resection and chemotherapy are standard of...

    Isobel P. Taylor, J. Alejandro Lopez in Journal of Cancer Research and Clinical Oncology
    Article Open access 08 April 2023
  18. Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells

    Aims/hypothesis

    The Coxsackie and adenovirus receptor (CAR) is a transmembrane cell-adhesion protein that serves as an entry receptor for...

    Eseoghene Ifie, Mark A. Russell, ... Sarah J. Richardson in Diabetologia
    Article Open access 03 August 2018
  19. Oncolytic viruses against cancer, promising or delusion?

    Cancer treatment is one of the most challenging topics in medical sciences. Different methods such as chemotherapy, tumor surgery, and immune...

    Arash Letafati, Omid Salahi Ardekani, ... Jila Yavarian in Medical Oncology
    Article 17 July 2023
  20. Subacute thyroiditis presenting as simple acute headache was misdiagnosed as meningitis: case report and literature review

    Background

    The relationship between headache and thyrotoxicosis has been occasionally mentioned in case reports, but there are few related reports....

    Cao Huang, Shuang Shen, Jianping Yao in BMC Endocrine Disorders
    Article Open access 07 March 2023
Did you find what you were looking for? Share feedback.